ProQR Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRQR and other ETFs, options, and stocks.About PRQR
ProQR Therapeutics NV is a clinical stage biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases with a focus on inherited retinal diseases. The company was founded by Daniel Anton de Boer, Gerard J.
PRQR Key Statistics
Stock Snapshot
With a market cap of 224.39M, ProQR Therapeutics(PRQR) trades at $1.63. The stock has a price-to-earnings ratio of -3.56.
On 2026-09-28, ProQR Therapeutics(PRQR) stock moved within a range of $1.62 to $1.78. With shares now at $1.63, the stock is trading +0.3% above its intraday low and -8.5% below the session's peak.
Trading activity shows a volume of 165.34K, compared to an average daily volume of 626.4K.
The stock's 52-week range extends from a low of $1.33 to a high of $3.10.
The stock's 52-week range extends from a low of $1.33 to a high of $3.10.
PRQR News
The latest update is out from ProQR ( (PRQR) ). On September 23, 2026, ProQR announced it has appointed Chris Hart as Chief Data and AI Officer and added Huggi...
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.